In 2024, there were a total of 7,146 deaths in Canada due to opioid overdose, with around 28 percent of deaths occurring among those aged 30 to 39 years. This statistic shows the distribution of deaths from opioid overdose in Canada from 2016 to 2024, by age.

In 2024, there were a total of 7,146 deaths in Canada due to opioid overdose, with around 74 percent of these deaths involving fentanyl. This statistic shows the share of deaths from opioid overdose in Canada from 2016 to 2024 that involved select drugs.

During 2024, there were a total of 7,146 deaths from opioid overdose in Canada, 2,231 of which occurred in the province of Ontario. This statistic shows the number of deaths from opioid overdose in Canada in 2024, by province. Opioid Use and Misuse Opioids are commonly prescribed as both short-term and long-term pain management strategies. Unfortunately, opioids are sometimes used problematically, including taking increased amounts, tampering with the route of administration, or using with the goal to improve mood, all of which can lead to addiction, overdose, and even death. In 2023, there were around 6,462 hospitalizations in Canada due to opioid poisoning. Opioid Crisis in Canada Among Canadian adults, the majority view the opioid issues of the country as a serious problem or a crisis. Moreover, many opioid deaths also involve the use of a stimulant, which adds to the polysubstance nature of the opioid crisis. Efforts against the opioid crisis in Canada are multi-faceted. One way is focused on reducing possible harm from using illicit opioid sources such as heroin or other street opioids through the use of opioid agonist treatment methods including methadone and naloxone.

In 2024, there were **** deaths from opioid overdose per 100,000 population in the province of British Columbia. This statistic shows the death rate from opioid overdose in Canada in 2024, by province, per 100,000 population.

In 2024, around 74 percent of opioid overdose deaths in the province of British Columbia were male. This statistic shows the distribution of deaths from accidental apparent opioid overdose in Canadian provinces in 2024, by gender.

In 2024, there were a total of ***** deaths in Canada due to opioid overdose. Of this total, around ***** deaths, or ** percent, were accidental overdose deaths. This statistic shows the number of deaths from opioid overdose in Canada from 2016 to 2024, by manner of death.

Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

In 2024, there were a total of ***** deaths in Canada due to opioid overdose, with around ** percent of deaths occurring among males. This statistic shows the distribution of deaths from opioid overdose in Canada from 2016 to 2024, by gender.

In 2024, around ** percent of opioid overdose deaths in Canada involved people aged 30 to 39 years. This statistic shows the distribution of accidental apparent deaths from opioid overdose in Canada in 2024, by age.

Snapshot img

What is the Size of Opioid Rescue Products Market?

The opioid rescue products market size is forecast to increase by USD 1.69 billion, at a CAGR of 11.6% between 2023 and 2028. The market is experiencing significant growth due to the escalating opioid overdose crisis in the US. According to the National Institute on Drug Abuse, over 130 Americans die daily from an opioid overdose. In response, the opioid industry is focusing on the development and approval of new drugs to address this public health concern. For instance, sublingual tablets and transdermal patches are gaining popularity as they offer quicker relief and improved treatment access for patients suffering from opioid overdoses. However, challenges persist, including the presence of counterfeit drugs and the management of comorbid illnesses such as constipation, which are common in opioid users. The approval of new drugs and the continued innovation in delivery systems will be crucial in addressing these challenges and reducing opioid-related deaths.

Request Free Opioid Rescue Products Market Sample

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

Distribution Channel

  Offline
  Online


Product Type

  Naloxone
  Naltrexone
  Others


Geography

  North America

    US


  Europe

    Germany
    UK
    France
    Spain


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

Which is the Largest Segment Driving Market Growth?

The offline segment is estimated to witness significant growth during the forecast period. Opioid rescue products, such as naloxone and naltrexone, play a crucial role in reversing the effects of opioid overdoses and treating opioid addiction. Pharmacies serve as essential distribution channels for these medications, making them easily accessible to the public. Prescriptions and, in certain cases, over-the-counter sales are options for obtaining these life-saving drugs.

Get a glance at the market share of various regions Download the PDF Sample

The offline segment was valued at USD 896.70 million in 2018. Major pharmacy chains significantly contribute to making opioid rescue products readily available. First responders, including paramedics, police officers, emergency medical technicians, and non-emergency medical personnel, are increasingly utilizing opioid rescue products. These professionals are often the first on the scene during an opioid overdose and can administer immediate intervention, which is vital in preventing fatalities. Non-governmental organizations also play a significant role in increasing awareness and providing training on the use of opioid rescue products to first responders and the general public.

Which Region is Leading the Market?

For more insights on the market share of various regions Request Free Sample

North America is estimated to contribute 46% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The opioid crisis is a major public health concern in North America, affecting both the United States and Canada. In the United States, during the 12 months ending in February 2023, over 105,000 reported opioid overdoses occurred, primarily due to synthetic opioids like illicit fentanyl. This startling figure highlights the importance of having effective opioid rescue products available to counteract the potentially fatal consequences of opioid overdoses. In Canada, the opioid overdose crisis continues to pose a significant threat to individuals, families, and communities. This crisis is considered one of the most severe public health crises in the country's recent history. Between January 2016 and June 2022, there were approximately 32,600 apparent opioid toxicity deaths. Opioid overdoses can lead to respiratory depression and psychological problems, making it crucial to have accessible and efficient opioid rescue products.

Opioid rescue products, such as naloxone and buprenorphine, play a vital role in reversing opioid overdoses. These medications can help restore normal breathing and prevent further harm. The ongoing opioid crisis necessitates the continuous development and availability of these essential treatments. In conclusion, the opioid crisis is a pressing issue in North America, with the US and Canada experiencing high numbers of opioid overdoses and fatalities. Effective opioid rescue products, like naloxone and buprenorphine, are essential in mitigating the devastating effects of opioid overdoses. It is crucial to ensure these treatments are accessible and readily available to those in need.

How do Technavio's company ranking index

In 2024, around ** percent of opioid overdose deaths in British Columbia involved fentanyl and ** percent of opioid deaths involved fentanyl analogues. This statistic shows the percentage of deaths from accidental apparent opioid overdose in Canada in 2024 involving fentanyl, by province or territory.

In 2024, around 80 percent of accidental opioid overdose deaths in British Columbia involved only non-pharmaceutical opioids. In comparison, 43 percent of accidental opioid overdose deaths in New Brunswick involved only pharmaceutical opioids. This statistic shows the distribution of deaths from opioid overdose in Canada in 2024, by province and opioid origin.

Snapshot img

Drugs Of Abuse Testing Market Size 2024-2028

The drugs of abuse testing market size is forecast to increase by USD 1.04 billion at a CAGR of 4.5% between 2023 and 2028. The market is experiencing significant growth, driven by increased strategic developments and the growing adoption of advanced information technology and information management solutions. These advancements in instruments enable efficient and accurate testing, reducing turnaround time and enhancing overall productivity. For instance, mass spectrometer and chromatography systems are extensively employed for the qualitative and quantitative analysis of cannabinoids in cannabis strains. However, high costs associated with the implementation and maintenance of these technologies remain a challenge for market expansion. Additionally, stringent regulations and the need for continuous innovation to keep up with emerging drugs of abuse are other key factors shaping the market landscape. Overall, the DoA testing market is expected to continue its growth trajectory, fueled by the need for workplace safety and substance abuse prevention.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market is driven by the increasing prevalence of prescription drug abuse, psychostimulants, fentanyl, vaping, and illicit drugs, as well as alcohol. Substance use disorders continue to be a significant public health concern in the US. Forensic laboratories and hospitals are major end-users, diagnostics with epidemiologic investigations and addiction treatment centers also contribute. Vulnerable populations such as the elderly, those with chronic pain, LIMS software, and individuals with opioid medications are key focus areas. Drugs like Fentanyl, psychostimulants, and cannabis/marijuana are common targets for testing.

Moreover, fentanyl, a powerful opioid, has emerged as a significant threat in the market. Its illegally manufactured forms are often mixed with other substances, making it difficult to detect and leading to a high number of overdose deaths. The elderly population is another vulnerable group in the market. They are at a higher risk of substance use disorders due to chronic pain and the misuse of prescription medications. Drug use statistics indicate that psychostimulants, such as cocaine and amphetamines, continue to be popular among certain demographics. Vaping, a newer form of drug delivery, has also gained popularity, particularly among the younger population.

Furthermore, real-time surveillance and epidemiologic investigations play a crucial role in identifying drug-related activity and addressing vulnerabilities in the market. Public awareness campaigns and drug testing mandates are essential tools in preventing substance use disorders and promoting addiction treatment. Cannabis, or marijuana, is another substance of interest in the market. While it is legal for medicinal and recreational use in some states, it is still illegal in others, making testing a necessity for employers and law enforcement agencies. The market is expected to grow due to the increasing need for accurate and reliable testing services. This growth is driven by the rising number of overdose deaths, addiction treatment initiatives, and public awareness campaigns.

In conclusion, the market is a critical component in addressing substance use disorders and promoting public health. It encompasses various sectors, including forensic laboratories and hospitals, and offers testing services for a range of substances, including prescription drugs, illicit drugs, and alcohol. The market is driven by various factors, including the increasing prevalence of substance use disorders, the emergence of new drugs and drug delivery methods, and the need for accurate and reliable testing services.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Instruments
  Consumables


Geography

  North America

    Canada
    US


  Europe

    Denmark


  Asia

    China
    India


  Rest of World (ROW)

By Product Insights

The instruments segment is estimated to witness significant growth during the forecast period. The market encompasses various systems, analyzers, and devices for detecting and quantifying different drug substances. These tools include breath analyzers, chromatography analyzers, immunoassay analyzers, urine testing devices, and oral fluid testing devices. For example, cannabis testing relies on mass spectrometers and chromatography systems to identify and measure the presence and quantity of cannabinoid compounds. Biotechnology plays a significant role in the market, as the principles of detection and quantification are similar to those used in food testi

Fentanyl Testing Market Outlook

According to our latest research, the global fentanyl testing market size reached USD 1.47 billion in 2024, reflecting the urgent need for effective drug screening solutions amid the escalating opioid crisis. The market is anticipated to grow at a robust CAGR of 8.3% from 2025 to 2033, with the market size projected to hit USD 2.95 billion by the end of the forecast period. This remarkable growth is primarily driven by the rising prevalence of fentanyl abuse, increasing government initiatives for drug monitoring, and technological advancements in rapid testing methods. As per the latest research, the global demand for fentanyl testing is being propelled by heightened awareness surrounding opioid-related fatalities and the critical need for timely detection in both clinical and forensic settings.

One of the primary growth factors for the fentanyl testing market is the alarming surge in opioid misuse, particularly synthetic opioids such as fentanyl, which are significantly more potent than morphine or heroin. The widespread availability and illicit distribution of fentanyl have led to a dramatic increase in overdose deaths, compelling healthcare systems and law enforcement agencies to adopt advanced testing solutions. Governments across the globe are intensifying their efforts to combat the opioid epidemic by mandating drug screening in various settings, including hospitals, rehabilitation centers, and workplaces. These regulatory measures, coupled with public health campaigns, are significantly boosting the adoption of fentanyl testing products, thereby fueling market expansion.

Technological advancements have also played a critical role in the growth of the fentanyl testing market. Innovations in point-of-care diagnostics, such as highly sensitive test strips and portable analyzers, have made it possible to detect fentanyl and its analogs rapidly and accurately. The integration of digital technologies with traditional testing methods has further enhanced the efficiency and reliability of results, making these solutions indispensable for healthcare providers, forensic laboratories, and law enforcement agencies. Additionally, the growing trend of home-based drug testing, facilitated by user-friendly and affordable test kits, is expanding the marketÂ’s reach to individual consumers and families concerned about opioid exposure.

Another significant driver is the increasing collaboration between public health authorities, law enforcement agencies, and private sector companies to develop comprehensive drug monitoring programs. These initiatives are not only focused on detection but also on prevention and intervention, thereby creating a holistic approach to tackling the fentanyl crisis. The availability of funding for research and development, coupled with favorable reimbursement policies in certain regions, is encouraging market players to invest in the development of next-generation testing solutions. As a result, the fentanyl testing market is witnessing a surge in product launches and strategic partnerships aimed at expanding product portfolios and enhancing distribution networks.

In parallel with the advancements in fentanyl testing, the emergence of Synthetic Cannabinoids Testing is gaining traction in the drug testing landscape. Synthetic cannabinoids, often referred to as "spice" or "K2," are a class of designer drugs that mimic the effects of THC, the active component in cannabis. These substances have been associated with severe health risks, including acute toxicity and unpredictable psychoactive effects. As a result, there is a growing demand for reliable testing solutions to detect these compounds in various settings, such as workplaces, rehabilitation centers, and law enforcement agencies. The development of advanced testing methods for synthetic cannabinoids is crucial for public health and safety, as it enables timely intervention and reduces the potential for abuse.

From a regional perspective, North America continues to dominate the global fentanyl testing market, accounting for the largest share in 2024, followed by Europe and Asia Pacific. The high incidence of opioid-related deaths in the United States and Canada, coupled with stringent regulatory frameworks and robust healthcare infrastructure, has cemented North AmericaÂ’s leadership positi

Narcotics Overdose Heatmap Dashboards Market Outlook

According to our latest research, the global Narcotics Overdose Heatmap Dashboards market size reached USD 1.12 billion in 2024, reflecting the growing urgency to address the opioid crisis and related drug overdose incidents worldwide. The market is expected to expand at a CAGR of 13.7% during the forecast period, with projections indicating a value of USD 3.37 billion by 2033. This robust growth is primarily driven by heightened demand for real-time, data-driven surveillance systems to support public health interventions, law enforcement, and emergency response strategies in combating narcotics-related fatalities and morbidity.

The accelerating adoption of digital health technologies and advanced analytics platforms is a significant growth factor for the Narcotics Overdose Heatmap Dashboards market. Governments and healthcare agencies are increasingly investing in sophisticated visualization tools that enable rapid identification of overdose hotspots, facilitating targeted interventions and resource allocation. The integration of artificial intelligence and machine learning into dashboard solutions enhances predictive capabilities, allowing stakeholders to anticipate emerging trends and respond proactively. This technological evolution not only improves operational efficiency but also empowers communities to implement data-informed public health policies, further fueling market expansion.

Another critical driver is the escalating opioid epidemic and the proliferation of synthetic narcotics such as fentanyl, which have led to unprecedented levels of overdose incidents globally. The need for actionable intelligence to monitor and manage these crises has never been more acute. Narcotics Overdose Heatmap Dashboards provide essential situational awareness by aggregating data from diverse sources, including hospitals, emergency medical services, law enforcement, and public health agencies. This comprehensive approach enables cross-sector collaboration and enhances the effectiveness of overdose prevention programs, contributing to the sustained growth of the market.

Policy mandates and funding initiatives from both governmental and non-governmental organizations are further stimulating the adoption of narcotics overdose heatmap dashboards. In many regions, regulatory frameworks now require real-time reporting and transparency in overdose data, compelling stakeholders to deploy robust dashboard solutions. Additionally, public-private partnerships and grants are supporting the development and implementation of these systems, particularly in underserved areas. The ongoing emphasis on public health surveillance and the prioritization of opioid crisis response at national and international levels are expected to maintain high demand for these platforms in the coming years.

Regionally, North America dominates the Narcotics Overdose Heatmap Dashboards market due to the severe impact of the opioid crisis in the United States and Canada, coupled with advanced healthcare infrastructure and strong policy support. Europe follows closely, driven by rising awareness and increasing investments in digital health solutions. The Asia Pacific region is emerging as a lucrative market, propelled by growing urbanization, expanding healthcare IT capabilities, and heightened focus on substance abuse prevention. Latin America and the Middle East & Africa are gradually adopting these technologies, supported by international aid and regional health initiatives, although market penetration remains comparatively lower.

Component Analysis

The Component segment of the Narcotics Overdose Heatmap Dashboards market is categorized into software, hardware, and services, each playing a pivotal role in the deployment and functionality of these solutions. The software component is the backbone of heatmap dashboards, encompassing advanced analytics engines, data aggregation modules, and intuitive visualization interfaces. As the opioid crisis intensif

In 2024, there were ****** emergency medical service (EMS) responses to suspected opioid overdose in British Columbia. This statistic shows the number of EMS responses to suspected opioid-related overdoses in Canada from 2017 to 2024, by region.

In 2024, around 73 percent of emergency medical service (EMS) responses to suspected opioid overdose in British Columbia were among males. This statistic shows the distribution of EMS responses to suspected opioid-related overdoses in Canada in 2024, by gender and region.